2023 ETF Series Trust - Brandes International ETF (BINV)
Assets
$542.70M
Brandes
Fee
0.69%
a year
Yield
2.2%
Components
66
top 10: 24%
Performance
The fund's own total return, a year on average over the longer periods; volatility is the yearly standard deviation of its returns.
This year
+14.0%
1 year
+17.2%
3 years
+22.1%
5 years
–
10 years
–
Volatility 15.3% over one year, 0.0% over three; Sharpe ratio over three years 0.00.
Largest components
| SAPSAP SE ADR | 3.62% | Technology | |
| SANSanofi SA | 2.65% | Healthcare | |
| 4502Takeda Pharmaceutical Co. Ltd. | 2.61% | Healthcare | |
| BABAAlibaba Group Holding Ltd | 2.45% | Consumer Cyclical | |
| PBR-APetróleo Brasileiro S.A. - Petrobras | 2.29% | Energy | |
| WALMEXWal-Mart de México S.A.B. de C.V. | 2.28% | Consumer Defensive | |
| 0IZ8Henkel AG & Co KGAA ST O.N. | 2.19% | Consumer Defensive | |
| 4503Astellas Pharma Inc. | 2.11% | Healthcare | |
| DEODiageo PLC ADR | 2.00% | Consumer Defensive | |
| HEIOHeineken Holding NV | 1.99% | Consumer Defensive |
Sectors
Consumer Defensive27.3%
Healthcare17.3%
Consumer Cyclicals15.4%
Technology8.5%
Communication Services8.2%
Industrials8.1%
Financial Services6.0%
Basic Materials3.0%
Energy3.0%
Utilities1.8%
Real Estate1.8%
Regions
Europe Developed42.4%
Latin America14.3%
United Kingdom14.0%
Japan12.4%
North America6.2%
Asia Emerging5.3%
Asia Developed3.6%
Africa/Middle East1.2%
Asset classes
Stock non-US96.9%
Stock US3.5%
Cash0.9%
About the fund
- Issuer
- Brandes
- Since
- 2023-10-03
- Listed on
- BATS
- ISIN
- US9009342091
- Turnover
- 0% a year
The fund is an actively managed exchange-traded fund ("ETF") that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase.
From the market data provider's fund data, read 2026-10-19. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.